PATENT CLAIM ANALYSIS

Application Number: 15892078
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["514", "561000"]

Abstract:
Compositions contain citrulline and leucine or a metabolite thereof including, for example, a synergistic amount of citrulline and leucine. Such compositions may be used in methods for the treatment of pre-diabetes, metabolic syndrome, hyperglycemia, or diabetes.

Claim (Index 13):
The method of  claim 1 , wherein the therapeutically effective amount of the citrulline and the therapeutically effective amount of the leucine or metabolite thereof is administered in conjunction with at least one additional treatment method, the at least one additional treatment method comprising administering at least one pharmaceutical composition comprising an active agent selected from the group consisting of: a sulfonylurea, a meglitinide, a biguanide, an alpha-glucosidase inhibitor, a thiazolidinedione, a DPP-IV inhibitor, a glucagon-like peptide (GLP)-1 analog, and insulin.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.3871
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15027580', '15891324', '14248787', '14851668', '15226267']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7040676095908356
- 35 USC 102 Novelty (BERT): 0.5524978665874617
- Combined Prediction Score: 0.6889106352904982
- Mean Citation Score: 259.033282
- Max Citation Score: 406.64493
- Similarity Product: 396.13551045277467

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test